Plain-English translation of NCT07374562 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a procedure called a stellate ganglion block — an injection of the medication bupivacaine near nerves in your neck — can help relieve long COVID symptoms. Half of participants will receive the actual injection, and half will receive a placebo (fake) injection with saline. Researchers will follow everyone for 26 weeks to see if this treatment helps with breathing problems, fatigue, brain fog, and quality of life.
Long COVID causes symptoms like shortness of breath, extreme fatigue, and trouble concentrating that can last months or years after infection. Currently, there are few proven treatments, so researchers are testing whether this medication injection might help by calming the nervous system.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic for a single injection procedure performed by an anesthesiologist using ultrasound guidance — either the active treatment or a placebo. After that, you'll return for follow-up visits over 26 weeks (about 6 months) where you'll answer questions about your symptoms, complete simple physical tests, and report on your fatigue, breathing, thinking clarity, and overall quality of life. The study team will monitor your safety throughout.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Canada